NCT06149338

Brief Summary

The rate of successful intubation and the required time for intubation, using Vie Scope and Macintosh Laryngoscope will be compared, in order to evaluate the efficacy of Vie Scope in comparison with Macintosh in expected easy airways. Hence, a prospective randomized controlled single-blind superiority clinical trial will be conducted. Inclusion criteria: patients of both sexes, positive or negative rapid test for COVID-19 or possible contamination, age ≥18 years old, BMI: 18.5 - 30 kg/m2, visualization of the glottis grade 1 or 2, according to Cormack-Lehane Classification. Exclusion criteria: age under 18 years old, BMI under 18.5 kg/m2 and BMI over 30 kg/m2, visualization of the glottis grade 3 - 4, according to Cormack-Lehane Classification. The laryngoscopy and intubation of the patients will be attempted by the same person-resident of Anesthesiology, under the supervision of experienced Anesthesiologist consultants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
264

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 20, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 26, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2024

Completed
4 months until next milestone

Results Posted

Study results publicly available

December 6, 2024

Completed
Last Updated

February 7, 2025

Status Verified

January 1, 2025

Enrollment Period

7 months

First QC Date

November 20, 2023

Results QC Date

October 16, 2024

Last Update Submit

January 24, 2025

Conditions

Keywords

Vie ScopeMacintoshRate of successful intubationIntubation time

Outcome Measures

Primary Outcomes (2)

  • Rate of Successful Intubation With One Attempt

    This outcome depends on whether the intubation of each patient will be successful or not, after the first attempt of intubation

    Evaluation immediately after the first attempt of intubation

  • Mean Intubation Time

    Mean time interval required for intubation, which is determined from the time of the insertion of the laryngoscope into the patient's mouth until the time of the inflation of the tube's cuff on each patient

    Assessment of the required mean time interval for intubation, immediately after the insertion of laryngoscope's blade into the patient's mouth

Secondary Outcomes (2)

  • Rate of Successful Intubation

    Evaluation immediately after the intubation attempts

  • Visualization of the Glottis, According to Cormack Lehane Classification

    This outcome will be evaluated during laryngoscopy and intubation of each patient

Study Arms (2)

Patients being intubated using Macintosh laryngoscope

EXPERIMENTAL
Device: Macintosh laryngoscope

Patients being intubated using Vie Scope laryngoscope

EXPERIMENTAL
Device: Vie Scope

Interventions

Macintosh laryngoscope has been the gold standard for endotracheal intubation since the middle of 20th century. During laryngoscopy and direct vision of the vocal cords, an endotracheal tube is passed into the trachea, establishing the airway.

Patients being intubated using Macintosh laryngoscope
Vie ScopeDEVICE

Vie Scope is a laryngoscope, whose function is relied on Seldinger technique. Firstly, bougie is passed through the translucent barrel of Vie Scope under direct vision between the vocal cords and into the trachea. Then, Vie Scope is removed and an endotracheal tube is passed over the bougie, which will be finally removed. The inflation of the endotracheal tube's cuff is followed by ventilation and confirmation of the tube placement.

Patients being intubated using Vie Scope laryngoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both sexes
  • Positive or negative rapid test for COVID-19 or possible contamination
  • Age ≥18 years old
  • BMI: 18.5 - 30 kg/m2
  • Visualization of the glottis grade 1 or 2, according to Cormack-Lehane Classification.

You may not qualify if:

  • Age under 18 years old
  • BMI under 18.5 kg/m2 and BMI over 30 kg/m2
  • Visualization of the glottis grade 3 - 4, according to Cormack-Lehane Classification.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saint Andrew's General Hospital of Patras

Pátrai, 263 32, Greece

Location

Limitations and Caveats

The airway operator was an anesthesiologist trainee with minimum experience. Thereby, the outcomes are not indicative of the Macintosh and Vie Scope use by consultants. Moreover, patients in both groups were not reassessed after endotracheal intubation, by direct laryngoscopy, in order to detect any potential complications. Finally, the current study was focused on the easy airway management of adults, providing no data about difficult airway management in adults and pediatric patients.

Results Point of Contact

Title
Dr. Vasileios Boviatsis
Organization
Saint Andrew's General Hospital of Patras

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 20, 2023

First Posted

November 29, 2023

Study Start

January 26, 2024

Primary Completion

August 21, 2024

Study Completion

August 21, 2024

Last Updated

February 7, 2025

Results First Posted

December 6, 2024

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations